Skip to main content
Year archive

Zur Rose Group AG — 2023 filings

All 59 regulatory filings released by Zur Rose Group AG (ROSE) in 2023, sourced directly from the official regulator.

59 Filings
2023 Period
2023 filings (59)
Filing Released Lang
Menschenrechtsrichtlinien
Environmental & Social Information
2023-12-11 German
Human Rights Policy
Environmental & Social Information
2023-12-11 English
Terms of Reference of the Compensation and Nomination Committee
Governance Information
2023-12-01 English
Terms of Reference of the Audit Committee
Audit Report / Information
2023-12-01 English
Reglement für den Prüfungsausschuss
Governance Information
2023-12-01 German
DocMorris optimises organisational structure and prepares for e-prescription growth in Germany
Board/Management Information
2023-11-22 English
DocMorris optimises organisational structure and prepares for e-prescription growth in Germany
Board/Management Information
2023-11-22 English
DocMorris AG: DocMorris optimiert Organisationsstruktur und stellt sich für E-Rezept-Wachstum in Deutschland auf
Board/Management Information
2023-11-22 German
Organisationsreglement
Governance Information
2023-11-07 German
DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook
Earnings Release 9M 2023
2023-10-19 English
DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook
Earnings Release 9M 2023
2023-10-19 English
DocMorris festigt im dritten Quartal den Pfad zu profitablem Wachstum; leicht reduzierter Umsatzausblick
Earnings Release 9M 2023
2023-10-19 German
DocMorris: Solid basis for sustainable, profitable growth
Earnings Release H1 2023
2023-08-17 English
DocMorris: Solid basis for sustainable, profitable growth
Earnings Release H1 2023
2023-08-17 English
DocMorris: Gefestigte Basis für nachhaltiges, profitables Wachstum
Earnings Release H1 2023
2023-08-17 German
Half-Year Results Presentation 2023
Investor Presentation H2 2023
2023-08-17 English
Halbjahresergebnis-Präsentation 2023 (englisch)
Investor Presentation H2 2023
2023-08-17 English
Halbjahres­bericht 2023
Interim / Quarterly Report H2 2023
2023-08-17 German
Half-Year Report 2023
Interim / Quarterly Report H2 2023
2023-08-17 English
DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions
Legal Proceedings Report
2023-07-06 English
DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions
Regulatory Filings
2023-07-06 English
DocMorris AG: DocMorris fordert diskriminierungsfreien volldigitalen Zugang zum E-Rezept
Regulatory Filings
2023-07-06 German
Organisational Regulations
Governance Information
2023-06-19 English
DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Capital/Financing Update
2023-05-26 English
DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Capital/Financing Update
2023-05-26 English
DocMorris gibt Resultate des Rückkaufangebots für ihre ausstehende CHF 200 Millionen-Anleihe mit Fälligkeit 2024 bekannt
Capital/Financing Update
2023-05-26 English
DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Capital/Financing Update
2023-05-12 English
DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Capital/Financing Update
2023-05-12 English
DocMorris (vormals Zur Rose Group) kündigt ein Rückkaufangebot für ihre ausstehende CHF 200 Millionen-Anleihe mit Fälligkeit 2024 an
Capital/Financing Update
2023-05-12 German
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
Regulatory Filings
2023-05-11 English
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
Report Publication Announcement
2023-05-11 English
Neues Börsen-Tickersymbol für DocMorris: DOCM (vormals RO-SE)
Regulatory Filings
2023-05-11 German
Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
AGM Information
2023-05-04 English
Zur Rose Group has successfully completed the sale of its Swiss business to Migros
Delisting Announcement
2023-05-04 English
Zur Rose Group has successfully completed the sale of its Swiss business to Migros
M&A Activity
2023-05-04 English
Zur Rose-Gruppe hat Verkauf des Schweizer Geschäft an Migros erfolgreich abgeschlossen
M&A Activity
2023-05-04 German
Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
AGM Information
2023-05-04 English
Generalversammlung 2023: Zur Rose Group AG wird in DocMorris AG umfirmiert (Börsen-Tickersymbol DOCM)
AGM Information
2023-05-04 German
Verkauf Schweizer Geschäft – Präsentation (englisch)
Capital/Financing Update
2023-05-01 German
Sale Swiss business – Presentation
Regulatory Filings
2023-05-01 English
Zur Rose Group: Revenue in the first quarter 2023 in line with plan
Earnings Release Q1 2023
2023-04-20 English
Zur Rose Group: Revenue in the first quarter 2023 in line with plan
Earnings Release Q1 2023
2023-04-20 English
Zur Rose-Gruppe: Umsatz im ersten Quartal 2023 im Rahmen der Planung
Earnings Release Q1 2023
2023-04-20 German
Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023
AGM Information
2023-04-12 English
Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023
AGM Information
2023-04-12 English
Zur Rose Group AG publiziert Einladung zur ordentlichen Generalversammlung vom 4. Mai 2023
AGM Information
2023-04-12 German
Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
Earnings Release FY 2022
2023-03-23 English
Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
Earnings Release FY 2022
2023-03-23 English
Zur Rose-Gruppe: Erreichung Umsatz- und Ergebnisziele 2022 und deutlicher Schritt in Richtung Profitabilität
Earnings Release FY 2022
2023-03-23 German
Annual Results Presentation 2022
Investor Presentation
2023-03-23 English
Annual Report 2022
Annual Report FY 2022
2023-03-23 English
Nachhaltig­keits­bericht 2022
Environmental & Social Information
2023-03-23 German
Annual Report 2022
Annual Report FY 2022
2023-03-22 English
Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany
M&A Activity
2023-02-03 English
Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany
M&A Activity
2023-02-03 English
Zur Rose-Gruppe übergibt erfolgreiches Schweizer Geschäft an Migros, um sich auf Wachstum in Deutschland zu konzentrieren
M&A Activity
2023-02-03 German
Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
Earnings Release FY 2022
2023-01-19 English
Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
Earnings Release FY 2022
2023-01-19 English
Zur Rose-Gruppe: Umsatzziel 2022 erreicht, Ergebnis besser als erwartet
Earnings Release FY 2022
2023-01-19 German